0001354457-12-000200.txt : 20120914
0001354457-12-000200.hdr.sgml : 20120914
20120914110810
ACCESSION NUMBER: 0001354457-12-000200
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20120914
DATE AS OF CHANGE: 20120914
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: NeurogesX Inc
CENTRAL INDEX KEY: 0001385830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943307935
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33438
BUSINESS ADDRESS:
STREET 1: 2215 BRIDGEPOINTE PARKWAY
STREET 2: SUITE 200
CITY: SAN MATEO
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-358-3300
MAIL ADDRESS:
STREET 1: 2215 BRIDGEPOINTE PARKWAY
STREET 2: SUITE 200
CITY: SAN MATEO
STATE: CA
ZIP: 94404
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NASDAQ Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
NASDAQ Stock Market LLC
0001385830
NeurogesX Inc
001-33438
2215 Bridgepointe Parkway, Suite 200
San Mateo
CA
CALIFORNIA
94404
650 358-3300
Common stock
17 CFR 240.12d2-2(b)
Amy Horton
Associate General Counsel
2012-09-14
EX-99.25
2
ngsxdelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
September 14, 2012, NeurogesX, Inc. The Nasdaq Stock
Market, Inc. (the Exchange) has determined to remove
from listing the common stock of NeurogesX, Inc.
(the Company), effective at the opening of the trading
session on September 24, 2012. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5450(b)(2)(A). The
Company was notified of the Staffs determination on
April 17, 2012. The Company appealed
the determination to a Hearing Panel.
Upon review of the information provided by the Company,
the Panel issued a decision dated June 27, 2012, denying
the Company continued listing and
notifying the Company that trading in the Companys
securities would be suspended on June 29, 2012.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company became
final on August 13, 2012.